New Research Poster Presentation 3.9: Modified Release Clonidine for the Treatment of Children and Adolescents with ADHD

Thursday, October 29, 2009 12:30 PM

Scott Kollins, Ph.D., Duke University Medical Center, Durham, NC

Robert L. Findling, M.D., University Hospitals Case Medical Center, Cleveland, OH

Sharon B. Wigal, Ph.D., University of California at Irvine, Child Development Center, Irvine, CA

Matthew Brams, M.D., Bayou City Research, Houston, TX

Scott D. Segal, M.D., Segal Institute for Clinical Research, North Miami, FL

Moise Khayrallah, Ph.D., Addrenex Pharmaceuticals, Inc., Durham, NC

		56th Annual Meeting Tentative Program Schedule
		Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 3.9 Modified Release Clonidine for the Treatment of Children and Adolescents with ADHD